ThreePoint Therapeutics
Status: Pending
Statusdato: 2026-09-10
Søknadsnummer: 202610993
Søknadsdato: 2026-09-10
Registreringsnummer: 1937030
Registreringsdato:
Innehaver: Contera Pharma A/S
Klasser: 5, 42
Internasjonal/Madrid-sak med virkning i Norge
Internasjonal registreringsdato: 2026-07-07
Varer og tjenester
Drugs for medical purposes; medicines for human purposes; pharmaceutical preparations; chemical preparations for pharmaceutical purposes; DNA and RNA for medical purposes; antibiotics; antivirals.
Research and development services in the field of pharmaceuticals and drug discovery; development of processes and methods for medical and veterinary purposes; development of preparations for medical and veterinary purposes; scientific research for medical purposes, namely, screening for the identification of drug candidates; development of precision RNA therapeutics; development of tailored RNA-based corrective interventions to target the root causes of serious diseases; research and development of new medical products for others; development and identification of novel druggable sites for pharmacological intervention using a bioinformatic discovery platform in a wet lab; screening services, bioinformatics services and modeling services to harness natural processes and modulate gene expression through platforms to generate optimized small molecules, antisense oligonucleotides (ASOs) and small interfering RNAs (siRNAs); designing and implementing multiplexed high-throughput assays to screen for small molecules that modulate RNA processing using bioinformatic tools; designing and developing algorithms and thermodynamic models.
Hendelser
Observert 2026-09-16T17:52:52.815Z
Hva ville du overvåket?
Varsling er ikke aktivert. Et valg registrerer bare grov interesse—ikke søkeord, fritekst eller e-post.
Kilde: Patentstyret. Varemerkeradar sorterer teknisk lignende ordmerker, men gir ikke juridisk rådgivning.
Om tjenesten · Datakilde og begrensninger · Personvern · Vilkår